Japanese medical technology company Terumo is working with California-based Glooko, a specialist in remote patient monitoring, to deliver diabetes data sharing.

This integration will enable people with diabetes to transfer recorded data from the Medisafe With insulin patch pump into the Glooko platform, thus helping them visualise insulin dosage, food and activities in graphs more easily and realise personalised remote patient monitoring and patient care more effectively.

The two companies will start offering this diabetes data option from next month, letting patients share their data with healthcare professionals easily both in the physicians’ office and remotely from home. This integration will allow healthcare professionals to view the patient’s latest health records more frequently, in-person at the clinic or remotely via Glooko’s analytics portal.

Additionally, both companies are working on a way of transferring recorded data from the Medisafe With insulin patch pump to the Glooko mobile app directly via NFC (near field communications), which is planned to be launched later this year. Medisafe With will be the first insulin patch pump with direct NFC connection to the Glooko mobile app, using patients’ personal smart phones to share their diabetes data with their diabetes team anytime, anywhere.

“We are excited to announce this new patient-focused collaboration with Glooko,” said Hikaru Samejima, president of Terumo’s general hospital company. “These will allow people with diabetes to upload their data from home easily without the need to visit the hospital. We believe this is valuable for both patients and healthcare providers especially under the post Covid-19 new normal lifestyle.”

Terumo has been a player in the diabetes market for around forty years, since 1982, providing globally products such as insulin injection needles, blood glucose meters and insulin pumps. In November 2020, Terumo obtained the CE mark for Medisafe With, and is expanding its product availability globally.

Glooko’s technology is used in 31 countries, digitally connecting people with diabetes and their healthcare professional teams. This integration enables more timely information sharing and more powerful remote patient management for better care.

“Our continued partnership with Terumo means even more access to health data for people with diabetes and their healthcare providers,” said Russ Johannesson, chief executive officer for Glooko. “We are very pleased to expand our partnership with Terumo by integrating Glooko’s data management and remote patient monitoring platform with the Medisafe With insulin patch pump. This means people with diabetes will be able to make more informed decisions with their data, and collaborate with their health care team. Those data include insulin, glucose, diet, activity and blood pressure. Having the best connectivity is imperative for delivering world class care, so we are happy to partner with Terumo to integrate its new insulin patch pump.”

Glooko is transforming digital health by connecting people with diabetes and other chronic conditions with their healthcare teams, enabling collaborative telehealth, clinical research and improved health outcomes. The company’s software collects and analyses data from multiple devices in one secure place, allowing for easy remote upload via app or in-clinic, and producing easy-to-read analytics through actionable charts and graphs.

The platform is compatible with over 95% of global diabetes and health monitoring devices, giving patients and their providers flexibility in how to manage their conditions. With more than 35 billion data points, Glooko has more than three million users in 31 countries across 22 languages.

Based in Tokyo and operating globally, Terumo employs more than 25,000 people worldwide to provide medical technology in more than 160 countries and regions. The company started as a thermometer manufacturer. Now, its portfolio ranges from vascular intervention and cardio-surgical products, blood transfusion and cell therapy technologies, to medical devices for daily clinical practice such as transfusion systems, diabetes care and peritoneal dialysis treatments.